TRAVASOL 10% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Travasol 10% In Plastic Container, and what generic alternatives are available?
Travasol 10% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in TRAVASOL 10% IN PLASTIC CONTAINER is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Travasol 10% In Plastic Container
A generic version of TRAVASOL 10% IN PLASTIC CONTAINER was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for TRAVASOL 10% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRAVASOL 10% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for TRAVASOL 10% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
McGill University Health Center | Phase 4 |
Canadian Institutes of Health Research (CIHR) | Phase 4 |
McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 4 |
Pharmacology for TRAVASOL 10% IN PLASTIC CONTAINER
Drug Class | Amino Acid |
Anatomical Therapeutic Chemical (ATC) Classes for TRAVASOL 10% IN PLASTIC CONTAINER
US Patents and Regulatory Information for TRAVASOL 10% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | TRAVASOL 10% IN PLASTIC CONTAINER | amino acids | INJECTABLE;INJECTION | 018931-003 | Aug 23, 1984 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |